Cybersecurity

Asia-Pacific is seeing a hiring boom in pharmaceutical cybersecurity roles

The proportion of pharmaceutical companies hiring for cloud related positions rose to a year-high in August 2021, with 42.7% of the companies included in our analysis recruiting for at least one such position.

India had the fastest growing demand for cybersecurity roles in the three months before November 2021

Powered by 

Asia-Pacific was the fastest growing region for cybersecurity hiring among pharmaceutical industry companies in the three months ending November.

The number of roles in Asia-Pacific made up 10.3 per cent of total cybersecurity jobs - up from 7.7 per cent in the same quarter in the previous year.

That was followed by North America, which saw a 0.3 year-on-year percentage point change in cybersecurity roles.

The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.

GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.

These key themes, which include cybersecurity, are chosen to cover "any issue that keeps a CEO awake at night".

By tracking them across job advertisements it allows us to see which companies are leading the way on specific issues and which are dragging their heels - and importantly where the market is expanding and contracting.

Which countries are seeing the most growth for cybersecurity roles in the pharmaceutical industry?

The fastest growing country was India, which saw 4.4 per cent of all cybersecurity job adverts in the three months ending November in 2020, increasing to seven per cent in the three months ending November last year.

That was followed by the United States (up 2.2 percentage points), Poland (up 1.9), and Germany (up 0.3).

The top country for cybersecurity roles in the pharmaceutical industry is the United States which saw 45.5 per cent of all roles in the three months ending November.

Which cities are the biggest hubs for cybersecurity workers in the pharmaceutical industry?

Some 5.4 per cent of all pharmaceutical industry cybersecurity roles were advertised in Bridgewater (United States) in the three months ending November - more than any other city.

That was followed by Bengaluru (India) with 5.4 per cent, Cambridge (United Kingdom) with 2.3 per cent, and Warsaw (Poland) with 2.1 per cent.

Go to article: Home | Cutting the carbon footprint of pharma’s supply chainGo to article: In this issueGo to article: ContentsGo to article: CSafe GlobalGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: HOF SonderanlagenbauGo to article: CommentGo to article: Is price control by stealth the future for the United States?Go to article: FDA approves Janus kinase inhibitors Rinvoq and Cibinqo despite safety concernsGo to article: Psychedelics: the next trip for CMOsGo to article: Over $1bn raised in venture capital funding for gene editing in 2021Go to article: SkyepharmaGo to article: In DepthGo to article: How AI could unlock the medical potential of psychedelicsGo to article: Covid-19 vaccine mixing: could heterologous boosters improve immunity?Go to article: Uneven supply patterns hinder US rollout of Covid-19 antiviralsGo to article: Cutting the carbon footprint of pharma’s supply chainGo to article: Molnupiravir supplies dominate in times of Paxlovid scarcityGo to article:  Wek-tec Go to article: In DataGo to article: Revealed: pharma leaders in precision, personalised medicineGo to article: Asia-Pacific is seeing a hiring boom in pharmaceutical cybersecurity rolesGo to article: Venture financing deals in pharma rise in H2 2021Go to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: Controlant Company InsightGo to article: ControlantGo to article: Event: Clinical Trial Supply New England 2022Go to article: EventsGo to article: Next issue